*Faculty of Medicine, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hacettepe University; and †Department of Cancer Control, Public Health Institute, Turkish Ministry of Health, Ankara, Turkey.
Int J Gynecol Cancer. 2017 Oct;27(8S Suppl 1):S1-S9. doi: 10.1097/IGC.0000000000001026.
The aim of this study was to evaluate nationwide gynecological cancer trends in Turkey.
National cancer registry data (2009-2013) of Turkish Ministry of Health were evaluated. Ovarian, cervical, endometrial, vulvar, vaginal, and tubal cancers are evaluated with respect to age of diagnosis, incidence rates within years, stage, histological distributions, and mortality rates. Data were collected from active cancer registry centers, which increased from 23% in 2009 to 47.5% coverage of the whole population by 2012, and mortality data (2010-2015) were obtained from the Turkish Statistical Institute.
A total of 16,023 gynecological cancers were evaluated among 116,940 female patients with cancer (13.7%). Average incidence for gynecological cancers was 22.7 of 100,000, representing 8437 total new cases annually. Incidence changes within time were not statistically significant, when evaluated for each tumor type. Estimated risk of gynecological cancer development before the age of 80 years was 3.08% (95% confidence interval, 3.07-3.09). The most common gynecological cancers were uterine corpus cancers, which were followed by ovarian and cervical carcinomas. Ovarian and uterine cancer incidences were closer to European levels rather than Asian countries, whereas cervical cancer incidence was extremely low. Gynecological cancers constituted an important fraction of cancer-related mortality in women by comprising approximately 10.35% of cancer-related deaths. Mortality rates due to gynecological cancers did not show a statistically significant increase within years.
This is the first national cancer registry report to be published for gynecological cancers by the Turkish Governmental Department. As a result, Turkish gynecological cancer epidemiological data were consistent with the data obtained from European and developed countries rather than Asian countries, except for cervical cancer incidence, which is extremely low.
本研究旨在评估土耳其全国妇科癌症趋势。
评估了土耳其卫生部国家癌症登记处的数据（2009-2013 年）。根据诊断年龄、年内发病率、分期、组织学分布和死亡率评估卵巢癌、宫颈癌、子宫内膜癌、外阴癌、阴道癌和输卵管癌。数据来自于活跃的癌症登记中心，这些中心的覆盖率从 2009 年的 23%增加到 2012 年的 47.5%，2010-2015 年的死亡率数据来自土耳其统计局。
在 116940 名患有癌症的女性患者中，共评估了 16023 例妇科癌症（13.7%）。妇科癌症的平均发病率为每 10 万人 22.7 例，每年有 8437 例新发病例。当评估每种肿瘤类型时，随时间变化的发病率没有统计学意义。在 80 岁之前发生妇科癌症的估计风险为 3.08%（95%置信区间，3.07-3.09）。最常见的妇科癌症是子宫体癌，其次是卵巢癌和宫颈癌。卵巢癌和子宫癌的发病率更接近欧洲水平，而不是亚洲国家，而宫颈癌的发病率极低。妇科癌症在女性癌症相关死亡中占重要比例，占癌症相关死亡的约 10.35%。妇科癌症的死亡率在年内没有显示出统计学上的显著增加。
这是土耳其政府部门首次发布的全国妇科癌症癌症登记报告。因此，土耳其妇科癌症的流行病学数据与欧洲和发达国家的数据一致，除了宫颈癌的发病率极低外，与亚洲国家的数据不一致。
